Several lines of evidence suggest that chronic activation of pro-inflammatory pathways in insulin target tissues, such as the adipose tissue, liver, muscle, and pancreatic islets may contribute to obesity, insulin resistance (IR), and T2DM (6). The gene discussed is INS; the disease is type 2 diabetes mellitus.